Keywords: |
leukemia; cancer surgery; gene mutation; mutation; histopathology; cancer risk; nuclear magnetic resonance imaging; chemoprophylaxis; ovary cancer; cohort studies; breast cancer; gene frequency; editorial; mutational analysis; breast neoplasms; brca1 protein; brca2 protein; heterozygote; risk assessment; self report; cancer genetics; dna; genes, brca1; genes, brca2; family history; malignant neoplastic disease; stomach cancer; hormonal therapy; medical documentation; kidney cancer; ethnic difference; risk reduction; testis cancer; dna determination
|